HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Adlercreutz Selected Research

2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)

8/2008Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohort.
7/2004Circulating enterolactone and risk of breast cancer: a prospective study in New York.
5/2004Highly elevated serum phyto-oestrogen concentrations in patients with diabetic nephropathy.
7/2003Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.
6/2001Determinants of serum enterolactone concentration.
4/2001Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
3/2001Urinary phytoestrogens and postmenopausal breast cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Adlercreutz Research Topics

Disease

12Neoplasms (Cancer)
01/2010 - 03/2000
9Breast Neoplasms (Breast Cancer)
01/2010 - 01/2000
5Cardiovascular Diseases (Cardiovascular Disease)
11/2001 - 08/2000
3Prostatic Neoplasms (Prostate Cancer)
11/2001 - 03/2000
2Carcinoma (Carcinomatosis)
02/2007 - 01/2003
2Adenoma (Adenomas)
08/2005 - 07/2003
2Carcinogenesis
07/2003 - 03/2000
2Osteoporosis
11/2001 - 09/2001
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2006
1Chronic Kidney Failure (Chronic Renal Failure)
05/2004
1Constipation
06/2001
1Alzheimer Disease (Alzheimer's Disease)
01/2001
1Inflammation (Inflammations)
01/2001
1Atherosclerosis
08/2000
1Coronary Disease (Coronary Heart Disease)
07/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2000
1Adenocarcinoma
03/2000

Drug/Important Bio-Agent (IBA)

7Phytoestrogens (Phytoestrogen)IBA
01/2010 - 12/2000
72,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
08/2008 - 03/2001
5LignansIBA
02/2008 - 03/2000
5Hormones (Hormone)IBA
12/2004 - 03/2000
4Estrogens (Estrogen)FDA Link
01/2010 - 01/2000
3GenisteinIBA
10/2001 - 03/2001
2Estrogen ReceptorsIBA
01/2010 - 11/2001
2Estradiol (Delestrogen)FDA LinkGeneric
02/2007 - 01/2003
22-MethoxyestradiolIBA
02/2007 - 01/2003
2IsoflavonesIBA
10/2001 - 09/2001
2daidzeinIBA
10/2001 - 09/2001
2Calcium-Binding ProteinsIBA
01/2001 - 03/2000
2AndrogensIBA
03/2000 - 03/2000
1catechol (pyrocatechol)IBA
01/2010
1Aromatase (CYP19)IBA
01/2010
1IsotopesIBA
01/2010
1Progesterone Receptors (Progesterone Receptor)IBA
02/2008
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
02/2007
1Plant ExtractsIBA
07/2006
1secoisolariciresinolIBA
08/2005
1EquolIBA
12/2004
1Urea (Carbamide)FDA LinkGeneric
01/2003
1Therapeutic UsesIBA
01/2003
1GlucosidesIBA
09/2001
1Proteins (Proteins, Gene)FDA Link
01/2001
1PhytochemicalsIBA
12/2000
1AntioxidantsIBA
08/2000
1LipidsIBA
08/2000
1EnzymesIBA
03/2000
1Prostate-Specific Antigen (Semenogelase)IBA
03/2000
1Catechol EstrogensIBA
03/2000
1Anti-Bacterial Agents (Antibiotics)IBA
03/2000
1Soybean Proteins (Soy Protein)IBA
03/2000
1CelluloseIBA
03/2000
1Sucrose (Saccharose)IBA
03/2000
1Starch (Cornstarch)IBA
03/2000
1ethyl acetateIBA
03/2000

Therapy/Procedure

1Transplantation
03/2000
1Estrogen Replacement Therapy
03/2000